Search results
Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Pari
PharmiWeb· 15 hours agoParis (France) and Cambridge (Massachusetts, USA), July 01st, 2024 – 07:00am CET – Biophytis SA (Euronext Growth Paris : ALBPS), ("Biophytis ...